Healx is a rare disease biotechnology company that uses generative AI for drug discovery.
Healx's investors include Balderton Capital, Amadeus Capital Partners, Atomico, Global Brain Corporation, Intel Capital.
Healx is headquartered in Cambridge, United Kingdom.
Healx is a rare disease biotechnology company that uses generative AI for drug discovery.
Healx is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Healx — Funding & Investors." VCBacked, July 1, 2025, https://www.vcbacked.co/company/healx. Accessed July 19, 2026.
VCBacked. (2025). Healx — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/healx
{{cite web |title=Healx — Funding & Investors |url=https://www.vcbacked.co/company/healx |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated